Particle size characterization in nanosuspensions often focuses on ‘majority’ features of the size distribution. Yet, for various suspensions in (bio)pharmaceuticals or fine chemicals, small fractions ...
Protein-based therapeutics have transformed treatments for numerous diseases, yet their production remains highly complex and cost-intensive [1][2],[3][4]. Downstream processing (DSP), including ...
Nanoparticles of increasingly smaller particle size and various material compositions are being developed for the pharmaceutical, biomedical, electronics, optoelectronics, energy, catalyst and ...
Dynamic Image Analysis directly addresses micro-flow imaging’s inherent scalability and workflow limitations. Both ...
Layered drug nanoparticles can now be produced efficiently and at scale using a microfluidic method that eliminates purification and improves consistency. Since its adaptation to nanoscale materials, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results